Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharbaco, officially known as Central Pharmaceutical Joint Stock Company No. 1, is one of Vietnam's oldest and most prominent pharmaceutical manufacturers, with a history dating back to 1954. The company specializes in the production and distribution of a wide range of pharmaceutical products, including antibiotics, analgesics, cardiovascular medications, and nutritional supplements. Pharbaco operates multiple manufacturing facilities that adhere to WHO-GMP standards and has been actively upgrading its infrastructure to meet EU-GMP requirements to facilitate international expansion. As a publicly traded entity on the UPCoM exchange, the company serves both the domestic Vietnamese market and various export markets. Its business model encompasses the full value chain from manufacturing and quality control to the distribution of generic medicines and medical equipment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharbaco Central Pharmaceutical.